1. Arrhythmias in a patient with metastatic melanoma treated with targeted therapy and implantable cardioverter defibrillator. (1st August 2017) Authors: Licciardello, M.; Giura, M.T.; Rozzo, G.; Marra, E.; Fava, P.; Astrua, C.; Contu, V.; Lista, P.; Fierro, M.T.; Quaglino, P.; Ribero, S. Journal: British journal of dermatology Issue: Volume 177:Number 2(2017) Page Start: 584 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Arrhythmias in a patient with metastatic melanoma treated with targeted therapy and implantable cardioverter defibrillator. (22nd June 2017) Authors: Licciardello, M.; Giura, M.T.; Rozzo, G.; Marra, E.; Fava, P.; Astrua, C.; Contu, V.; Lista, P.; Fierro, M.T.; Quaglino, P.; Ribero, S. Journal: British journal of dermatology Issue: Volume 177:Number 2(2017) Page Start: 584 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bexarotene as maintenance treatment after therapies other than skin‐directed therapy in advanced‐stage mycosis fungoides: a pilot study. (27th May 2019) Authors: Pileri, A.; Fava, P.; Fuligni, F.; Gunnella, S.; Guglielmo, A.; Astrua, C.; Grandi, V.; Simontacchi, G.; Patrizi, A.; Quaglino, P.; Pimpinelli, N. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 10(2019) Page Start: e367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cutaneous adverse reactions following SARS‐CoV‐2 vaccine booster dose: a real‐life multicentre experience. (10th July 2022) Authors: Avallone, G.; Cavallo, F.; Astrua, C.; Caldarola, G.; Conforti, C.; De Simone, C.; di Meo, N.; di Stefani, A.; Genovese, G.; Maronese, C.A.; Marzano, A.V.; Parente, R.; Quaglino, P.; Roccuzzo, G.; Tassone, F.; Zalaudek, I.; Senetta, R.; Ribero, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 11(2022) Page Start: e876 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Favourable prognostic role of regression of primary melanoma in AJCC stage I–II patients. (December 2013) Authors: Ribero, S.; Osella‐Abate, S.; Sanlorenzo, M.; Savoia, P.; Astrua, C.; Cavaliere, G.; Tomasini, C.; Senetta, R.; Macripò, G.; Bernengo, M.G.; Quaglino, P. Journal: British journal of dermatology Issue: Volume 169:Number 6(2013:Dec.) Page Start: 1240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Intestinal involvement in toxic epidermal necrolysis. A case report and review of literature. (23rd April 2014) Authors: Fava, P.; Astrua, C.; Cavaliere, G.; Brizio, M.; Savoia, P.; Quaglino, P.; Fierro, M.T. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 9(2015:Sep.) Page Start: 1843 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. MiR‐155 expression in Primary Cutaneous T‐Cell Lymphomas (CTCL). (3rd March 2016) Authors: Fava, P.; Bergallo, M.; Astrua, C.; Brizio, M.; Galliano, I.; Montanari, P.; Daprà, V.; Novelli, M.; Savoia, P.; Quaglino, P.; Fierro, M.T. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 1(2017:Jan.) Page Start: e27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab. Issue 14 (September 2015) Authors: Valpione, S.; Martinoli, C.; Fava, P.; Mocellin, S.; Campana, L.G.; Quaglino, P.; Ferrucci, P.F.; Pigozzo, J.; Astrua, C.; Testori, A.; Chiarion-Sileni, V. Journal: European journal of cancer Issue: Volume 51:Issue 14(2015:Sep.) Page Start: 2086 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab. Issue 14 (September 2015) Authors: Valpione, S.; Martinoli, C.; Fava, P.; Mocellin, S.; Campana, L.G.; Quaglino, P.; Ferrucci, P.F.; Pigozzo, J.; Astrua, C.; Testori, A.; Chiarion-Sileni, V. Journal: European journal of cancer Issue: Volume 51:Issue 14(2015:Sep.) Page Start: 2086 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Reply to 'The first dose of COVID‐19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?' by Damiani G et al. (4th February 2022) Authors: Avallone, G.; Giordano, S.; Astrua, C.; Merli, M.; Senetta, R.; Conforti, C.; Ribero, S.; Marzano, A.V.; Quaglino, P. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 6(2022) Page Start: e433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗